º£½ÇÊÓÆµ

Oops.

Our website is temporarily unavailable in your location.

We are working hard to get it back online.

PRIVACY
Retail & Consumer

Aim-listed Inspecs sets sights on growth after narrowed 2021 loss

The Bath-based eyewear group saw a rise in revenue and operating costs after a year of expansion

Robin Totterman is chief executive of Inspecs(Image: Inspecs)

Designer eyewear group Inspecs has reported a reduced loss after a year of acquisition and production expansion saw a fivefold rise in revenue.

The AIM-listed company, which is headquartered in Bath, completed a series of deals in 2021, including for German frames distributor BoDE Design, global design and licensing company Ego Eyewear. It also secured the trademarks, rights and licences for British fashion brand Hardy Amies.

In a set of final results for the year ended December 31 2021, group revenue jumped by 420% to £202.3 from £38.9m a year earlier.

Adjusted Underlying EBITDA - a measure of profitability - increased 376% to £22.6m from £4.7m in 2020, while gross profit was up 465% to £95m from £16.8m.

This helped the company to a narrowed loss after tax of £4.4m, a 39% reduction from the £7.3m accrued in 2020.

Inspecs, which designs, manufactures and distributes frames and lenses to a network of opticians and retailers spanning 80 countries, said it had sold 10.4 million eyewear units globally last year - up 112% from 4.9 million in the previous period.

Inspecs' global operations also include offices in Portugal, Scandinavia, the US and China, as well as a manufacturing site in Italy.

Bosses said among the firm’s operational highlights for 2021 was the construction and fit out of a lens-making facility in Gloucester for Norville - the manufacturing arm of a glasses company it bought out of administration for £2.4m in 2020.